Long-term benefits of early and high doses of interferon beta-1a treatment in relapsing-remitting multiple sclerosis

Clin Neurol Neurosurg. 2002 Jul;104(3):244-8. doi: 10.1016/s0303-8467(02)00046-x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Adjuvants, Immunologic / pharmacology*
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Glycosylation
  • Humans
  • Injections, Intramuscular
  • Injections, Subcutaneous
  • Interferon beta-1a
  • Interferon-beta / administration & dosage*
  • Interferon-beta / pharmacology*
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / pathology
  • Recurrence
  • Treatment Outcome

Substances

  • Adjuvants, Immunologic
  • Interferon-beta
  • Interferon beta-1a